MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model.
暂无分享，去创建一个
W. Watkins | K. Nakayama | K. Hoshino | Kumi Yoshida | M. Ohtsuka | A. Cho | T. Ohta | Y. Yokomizo | V. Lee | J. Watanabe | H. Ishida | Ken-ichi Yoshida | M. Palme | Jason Z. Zhang | Noriko Kuru | A. Sakamoto | H. Kawato